The owner of TerryWhite Chemists has just paid $9.5 million for a stake in an app

Adam Berry/Getty Images

MedAdvisor, the maker of a medication management app, has just raised $9.5 million from EBOS, the owner of pharmacy brand TerryWhite Chemist.

The deal, which sees EBOS with 14% of MedAdvisor, will help the app move into hospital groups and better target locally-owned pharmacies.

The cash will also be used to help MedAdvisor explore opportunities in the US, UK and New Zealand.

The app registers and tracks prescriptions digitally, allowing patients to skip the queue and order their refills over the app.

It also tracks patients’ dosages and reminds them when they are running low on prescription medication.

EBOS, listed on both the New Zealand Securities Exchange (NZX) and the ASX, is a wholesaler and distributor of healthcare, medical and pharmaceutical products.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.